For early-stage HCC, DKK1 demonstrated superior diagnostic accuracy (AUROC 0.85 vs. 0.658 for AFP), with higher sensitivity (70.9% vs. 54.4%) and specificity (84.7% vs. 69.3%). Here, DKK1 is linked to hepatocellular carcinoma.